전문정보검색
No | 제목 / 내용 |
---|---|
1 |
Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onse There are many treatment options available for men with metastatic castration-resistant prostate cancer (mCRPC). Yet, biomarkers predi |
2 |
Interim results of aasur: A single arm, multi-center phase 2 trial of apalutamide (A) + abirater Very high risk, Urology, Prostate cancer, Prednisone, Node negative, Medicine, Interim, Apalutamide, Abiraterone acetate |
3 |
Search for heavy neutral leptons in W plus . mu plus mu +/- jet decays |
4 |
Differences in the tumor genomic landscape between African Americans (AA) and Caucasians (CA) ad 5058 Background: Emerging data suggest differences in the tumor genomic profile of AA compared with CA men aPC. We hypothesized that t |
5 |
Landscape of circulating tumor DNA (ctDNA) abnormalities in advanced prostate cancer (aPCa): Dis 156 Background: AA have substantially higher prostate cancer incidence rates, are diagnosed at a younger age and with more advanced st |
6 |
Interim results of aasur: A single arm, multi-center phase 2 trial of apalutamide (A) + abirater 5012 Background: Standard of care in VHR PCa is radiation therapy (RT) with 18-36 months (mos) androgen-deprivation (ADT). With this r |
7 |
Association of genomic alterations (GAs) in circulating tumor DNA (ctDNA) with progression on ab Prostate cancer, Prednisone, Medicine, Enzalutamide, Circulating tumor DNA, Cancer research, Androgen, Abiraterone acetate |
8 |
Germline variant alleles in rs12422149 of SLCO2B1 and response to abiraterone acetate (AA) in me Variant allele, Prostate cancer, Predictive biomarker, Medicine, Germline, Castration resistant, Cancer research, Abiraterone acetat |
9 |
Independent assessment of TP53 and PTEN as predictors of response to enzalutamide (ENZ) or abira PTEN, Prostate cancer, Primary tumor, Oncology, Medicine, Internal medicine, Enzalutamide, Castration, Androgen receptor, Androgen, |
10 |
Germline variant in SLCO2B1 and response to abiraterone acetate plus prednisone (AA) in men with Single-nucleotide polymorphism, Prostate cancer, Prednisone, Oncology, Medicine, Internal medicine, Genotyping, Genotype, Clinical e |